EligibleTrials

Diaphragmatic Function as a Biomarker

Recruiting · NCT05903001 · Observational (researchers observe without assigning treatment) · Lead sponsor: RWTH Aachen University

View the official record on ClinicalTrials.gov →
HypertensionCOPDAsthma

Interventions studied

6-minute walking distance60 seconds sit-to-stand testBorg scaleCAT-QuestionnaireDiaphragm UltrasoundElectromyographyEuropean Society of Cardiology (ESC)/ European Respiratory Society (ERS) risk groupGINA classification of AsthmaIntercostal Muscle UltrasoundLung FunctionMRC Breathlessness ScaleMeasurement of respiratory mouth pressureRespiratory QuestionaireSNIP

What this trial is about

Dyspnea is among the most common symptoms in patients with respiratory diseases such as Asthma, chronic obstructive pulmonary disease (COPD), Fibrosis, and Pulmonary Hypertension. However, the pathophysiology and underlying mechanisms of dyspnea in patients with respiratory diseases are still poorly understood. Diaphragm dysfunction might be highly prevalent in patients with dyspnea and respiratory diseases. The association of diaphragm function and potential prognostic significance in patients with respiratory diseases has not yet been investigated.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

3 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.